Inhibrx Biosciences Inc.

INBX | NASDAQ

Price Alert Chart Builder DCF Calculator

$113.98

+$1.94 (+1.73%)

Sep 22, 2026, 9:38 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-140.06M	1.69B	-239.73M	-145.23M	-81.77M	-76.12M
Depreciation & Amortization	2.48M	2.29M	1.19M	1.23M	1.2M	1.02M
Stock-Based Compensation	11.14M	58.52M	24.85M	20.45M	15.05M	5.02M
Other Working Capital	-4.56M	33.77M	13.76M	3.74M	-1.67M	-5.61M
Other Non-Cash Items	4.25M	-1.99B	5.03M	5.09M	2.73M	11.56M
Deferred Income Tax	n/a	n/a	n/a	n/a	-9K	-2.14M
Change in Working Capital	-7.61M	52.05M	15.35M	3.16M	-17.52M	12.69M
Operating Cash Flow	-129.79M	-194.41M	-193.31M	-115.3M	-80.32M	-47.97M
Capital Expenditures	-31K	-2.6M	-4.59M	-686K	-864K	-1.36M
Cash Acquisitions	3K	n/a	n/a	n/a	55K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-28K	-2.6M	-4.59M	-686K	-809K	-1.36M
Debt Repayment	99.84M	n/a	n/a	n/a	39.99M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-340K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	128.81M	-42K	166.46M
Financial Cash Flow	101.45M	71.68M	201.96M	258.55M	83.77M	166.46M
Net Cash Flow	-28.38M	-125.33M	4.06M	142.56M	2.64M	117.12M
Free Cash Flow	-129.83M	-197.01M	-197.9M	-115.99M	-81.19M	-49.33M
Adj. Free Cash Flow	-140.96M	-255.52M	-222.75M	-136.44M	-96.24M	-54.36M
Maintenance CapEx	n/a	-2.6M	-4.59M	-686K	-864K	n/a
Growth CapEx	-31K	n/a	n/a	n/a	n/a	-1.36M
Owner Earnings	-129.79M	-197.01M	-197.9M	-115.99M	-81.19M	-47.97M